Document is current
Any future updates will be listed below
-
Authors
Hermann, Ruben https://orcid.org/0000-0002-1920-6450
Shovlin, Claire L. https://orcid.org/0000-0001-9007-5775
Kasthuri, Raj S. https://orcid.org/0000-0001-6672-3082
Serra, Marcelo
Eker, Omer F.
Bailly, Sabine
Buscarini, Elisabetta
Dupuis-Girod, Sophie https://orcid.org/0000-0002-8834-5526
- License Information
-
More Information
Article History
Accepted: 29 November 2024
First Online: 9 January 2025
Competing interests
: C.L.S. is listed as the inventor in the patent application filed by Imperial College London for the use of MEK1 inhibitors to treat telangiectasia in HHT (European Patent Application 23705641.1). O.F.E. is a consultant for Microvention, CERENOVUS and Balt, and is also a member of DSMB and on the advisory board for STREAM Study. All other authors declare no competing interests.
